Blog Voices from the Frontlines
By Todd R. Hansen for the Daily Republic
FAIRFIELD — California, one of the original eight states to legalize medical cannabis use, received a “B+” in the 2017 annual report by Americans for Safe Access.
Overall, the organization said there is still a lot of work to do, as none of the 44 states that allow medical marijuana use received an “A” grade. However, the number of states receiving a “B” or higher went from 11 to 19.
“Medical cannabis laws are moving in a positive direction, but only a handful of the 44 medical cannabis states are truly meeting the needs of patients, and there are still six states where cannabis remains completely illegal for patients,” Steph Sherer, executive director of Americans for Safe Access, said in a statement released with the annual report.
By Carl Wellstone for Weed News
Americans for Safe Access (ASA) have been at the forefront of the movement to implement sensible cannabis laws that benefit patients battling severe and debilitating medical conditions since the organization was founded in 2002. Led by a great advocate, Steph Sherer, ASA now has over 30,000 members in with chapters in forty different states. The Washington DC-based organization has been instrumental in progress we have seen at the federal level, such as the introduction of the bipartisan CARERS Act last session. With as much knowledge on medical cannabis policy as any group, ASA has just released its report of state medical marijuana laws and it is an interesting read that illustrates the patchwork of laws across the nation and provides a grade based upon a variety of factors.
This blog was originally published 10/31/13.
Cannabis and its derivatives have been documented for anti-epileptic effects since 1881. Today, the promise of cannabidiol (CBD) as an anti-epileptic treatment is prompting people to move to states that have safe access to medicinal products containing this compound. There are increasing reports of CBD being used by parents to treat seizure disorders in their children. This use of a cannabinoid to treat seizures is not unfounded, the ever-popular THC molecule has been studied in children with seizure disorders. The results of early cannabinoid clinical studies and anecdotal findings for epilepsy are promising.
By Larry Gabriel for the Detroit Metro Times
Recently, in this era of so-called fake news and alternative facts, the organization Americans for Safe Access (ASA) struck a blow for truth in the Drug Enforcement Administration's information about marijuana.
By NBCnews for WMGT 41
Mike Liszewski, director of government affairs for the medical marijuana advocacy group Americans for Safe Access, said the reassurances “provided little comfort.” “Sessions has yet to make such a commitment to respect state medical cannabis laws,”
Liszewski said in a statement.
By George Lettis for WBAL-TV 11 Baltimore
From the complicated science of cannabis to the practical issues of a business, Americans for Safe Access also trains people to deal with the legal limbo of medical marijuana.
By Debra Borchardt for Forbes
We prepared this document to help inform Congress about four important changes in the DEA’s positions on medical cannabis that could have an impact on their policy making decisions this session: cannabis is not a 'gateway drug' and it does not cause cognitive decline, psychosis or lung cancer. - Beth Collins
Americans for Safe Access Urges Members of Congress to Stop Using False Information About Marijuana
Washington, DC — Today, Americans for Safe Access, a national nonprofit dedicated to ensuring safe and legal access to medical cannabis for therapeutic use and research, sent a memo to Congress informing members that the Drug Enforcement Administration (DEA) has removed false information about cannabis from its website after months of public pressure. The memo explains;
Forty-four states now allow patients under their physician's care to use medical cannabis (marijuana) in some form, and the majority of the rest of the states are discussing medical cannabis in their current legislative sessions. In addition, three cannabis related budget amendments and four bills have been introduced so far in the 115th Congress.
We know that you rely on the Drug Enforcement Administration (DEA) to provide current and accurate information when you are making decisions about cannabis policy. Americans for Safe Access (ASA) has prepared this memo to inform you about four important changes in the DEA’s positions on medical cannabis that could have an impact on your policy making decisions this session.
View the memo here: http://www.safeaccessnow.org/iqa_memo
By Vince Sliwoski for the Portland Mercury
Was the DEA forced to remove “alternative facts” about cannabis from its website?
YES! IN DECEMBER, the medical marijuana advocacy group, Americans for Safe Access (ASA), formally requested that the federal Drug Enforcement Agency (DEA) remove or correct a cluster of misinformation on medical cannabis from its website. Shortly thereafter, DEA complied.
By Christine Vestal for the Huffington Post
Enacted in 2014, New York’s medical marijuana law is considered among the most cautious in the nation. Americans for Safe Access, a patient advocacy group, gives the state a letter grade of C when it comes to balancing product safety and ease of access to the emerging medicine.